HURA vs IBO

TuHURA Biosciences, Inc. vs Impact BioMedical, Inc. — Valuation Comparison 2026

HURA

Biotechnology
TuHURA Biosciences, Inc.
Quality
2.9
out of 10
Value Trap
43
WARN
Price
$2.35
Last close
Models
7/13
Active
VS

IBO

Biotechnology
Impact BioMedical, Inc.
Quality
4.4
out of 10
Value Trap
20
SAFE
Price
$0.51
Last close
Models
6/13
Active

Model-by-Model Comparison

ModelType HURA Fair ValueHURA Upside IBO Fair ValueIBO Upside
Bayesian DCF Intrinsic $0.31 -87.0% $0.12 -76.3%
First Chicago Scenario $•••.•• ••.•% $•••.•• ••.•%
ML-RIV Intrinsic $•••.•• ••.•% $•••.•• ••.•%
Dynamic NAV Asset-Based $1.06 -55.1% $0.02 -95.1%
PWERM Option-Based $•••.•• ••.•% $•••.•• ••.•%
Regime Cross-Sectional Relative $•••.•• ••.•% $•••.•• ••.•%
Sentiment SOTP Hybrid $•••.•• ••.•% $•••.•• ••.•%
CUCE Ensemble Ensemble $•••.•• ••.•% $•••.•• ••.•%
🔒

Unlock Full 13-Model Comparison

Access all valuation models for HURA vs IBO — including EROIC Spread, First Chicago, Markov DDM, PWERM, and 7 more.

Access Full Analysis — From $27/mo →

HURA vs IBO — Which Stock Is More Undervalued?

IBO scores higher with a 4.4/10 quality rating vs HURA's 2.9/10. Both stocks are analyzed daily using SEC EDGAR filings across 13 independent models.

Comparing TuHURA Biosciences, Inc. (HURA) and Impact BioMedical, Inc. (IBO) across 13 institutional-grade valuation models reveals how each company's intrinsic value stacks up against its market price. CirclFi's engine processes SEC EDGAR 10-K and 10-Q filings, FRED macroeconomic data, and GDELT news sentiment to generate independent fair value estimates daily.

HURA currently trades at $2.35 with a QOC of 2.9/10, while IBO trades at $0.51 with a QOC of 4.4/10.

Both companies are analyzed with models spanning intrinsic (Bayesian DCF, EPV), scenario-based (First Chicago), regime-switching (Markov DDM, RCMH-DCF), machine learning (ML-RIV, FTNN Topology), and ensemble methods (CUCE).